Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer
Introduction: Ovarian cancer is a leading cause of gynaecological cancer mortality. Ca125, the most widely used serum biomarker, has limited sensitivity for early-stage and type I tumours, prompting evaluation of additional blood-based markers. This umbrella review assesses the diagnostic and prognostic performance of serum and blood biomarkers in ovarian cancer.
Authors
- Georgia Zachou (ORCID: https://orcid.org/0000-0001-5792-4747)
- A. Michael
- Rui Wu
Institutions
- Royal College of Surgeons of England (GB)
- Royal Surrey County Hospital (GB)
- University of Surrey (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Royal Surrey NHS Foundation Trust (GB)
Publication Details
- Journal
- Academia oncology.
- Published
- 2026-03-27
- DOI
- https://doi.org/10.20935/acadonco8189
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00